Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphoma. Olszewski AJ, Treaba DO, Winter A, Donnelly S, et al. Br J Haematol 2025 Sep 21. doi: 10.1111/bjh.70178.

Read + Share

Amedeo Smart

Independent Medical Education

Olszewski AJ, Treaba DO, Winter A, Donnelly S, et al. Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphoma. Br J Haematol 2025 Sep 21. doi: 10.1111/bjh.70178.
PMID: 40976986